Regulatory T cells under scrutiny (original) (raw)

• Gershon, R. K. & Kondo, K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723–737 (1970). The first article to show that T cells can suppress immune responses in an antigen-specific manner.
  CAS PubMed PubMed Central Google Scholar
• Moller, G. Do suppressor T cells exist? Scand. J. Immunol. 27, 247–250 (1988).
  CAS PubMed Google Scholar
• Shanmugam, A. et al. Healthy monozygous twins do not recognize identical T-cell epitopes on the myelin basic protein autoantigen. Eur. J. Immunol. 24, 2299–2303 (1994).
  CAS PubMed Google Scholar
• Bach, J. M. et al. High-affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10, 375–386 (1997).
  CAS PubMed Google Scholar
• Ohashi, P. S. et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral-antigen-transgenic mice. Cell 65, 305–317 (1991).
  CAS PubMed Google Scholar
• Miller, J. F. Effect of thymectomy in adult mice on immunological responsiveness. Nature 208, 1337–1338 (1965).
  CAS PubMed Google Scholar
• Nishizuka, Y. & Sakakura, T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753–755 (1969). Day-3 thymectomy of non-autoimmune-prone BALB/c mice induces autoimmune disease (ovaritis).
  CAS PubMed Google Scholar
• Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J. Exp. Med. 184, 387–396 (1996). The polyautoimmune syndrome that is induced by day-3 thymectomy can be prevented by the administration of purified CD4+CD25+ T cells.
  Article CAS PubMed Google Scholar
• Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164 (1995).
  CAS PubMed Google Scholar
• Dardenne, M., Lepault, F., Bendelac, A. & Bach, J. F. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol. 19, 889–895 (1989).
  CAS PubMed Google Scholar
• Wick, G., Kite, J. H. Jr & Witebsky, E. Spontaneous thyroiditis in the obese strain of chickens. IV. The effect of thymectomy and thymo-bursectomy on the development of the disease. J. Immunol. 104, 54–62 (1970).
  CAS PubMed Google Scholar
• Penhale, W. J., Farmer, A., McKenna, R. P. & Irvine, W. J. Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin. Exp. Immunol. 15, 225–236 (1973).
  CAS PubMed PubMed Central Google Scholar
• Fowell, D. & Mason, D. Evidence that the T-cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T-cell subset that inhibits this autoimmune potential. J. Exp. Med. 177, 627–636 (1993). Sub-lethal irradiation of adult thymectomized rats induces diabetes and thyroiditis. The onset of these two diseases can be prevented by infusion of CD4+RT6+ T cells.
  CAS PubMed Google Scholar
• Powrie, F. & Mason, D. OX-22highCD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. 172, 1701–1708 (1990).
  CAS PubMed Google Scholar
• Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. & Coffman, R. L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5, 1461–1471 (1993). Reconstitution of BALB/c severe combined immunodeficient (SCID) mice with CD45RB hi T cells (in the absence of CD45RB low T cells) induces immune-mediated colitis.
  CAS PubMed Google Scholar
• Lafaille, J. J., Nagashima, K., Katsuki, M. & Tonegawa, S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T-cell receptor-transgenic mice. Cell 78, 399–408 (1994).
  CAS PubMed Google Scholar
• Kurrer, M. O., Pakala, S. V., Hanson, H. L. & Katz, J. D. β-cell apoptosis in T-cell-mediated autoimmune diabetes. Proc. Natl Acad. Sci. USA 94, 213–218 (1997).
  CAS PubMed PubMed Central Google Scholar
• Gonzalez, A., Andre-Schmutz, I., Carnaud, C., Mathis, D. & Benoist, C. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nature Immunol. 2, 1117–1125 (2001).
  CAS Google Scholar
• Surh, C. D. & Sprent, J. Regulation of naive and memory T-cell homeostasis. Microbes Infect. 4, 51–56 (2002).
  CAS PubMed Google Scholar
• Jameson, S. C. Maintaining the norm: T-cell homeostasis. Nature Rev. Immunol. 2, 547–556 (2002).
  CAS Google Scholar
• Theofilopoulos, A. N., Dummer, W. & Kono, D. H. T-cell homeostasis and systemic autoimmunity. J. Clin. Invest. 108, 335–340 (2001).
  CAS PubMed PubMed Central Google Scholar
• Barthlott, T., Kassiotis, G. & Stockinger, B. T-cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197, 1–11 (2003).
  Google Scholar
• Almeida, A. R., Legrand, N., Papiernik, M. & Freitas, A. A. Homeostasis of peripheral CD4+ T cells: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T-cell numbers. J. Immunol. 169, 4850–4860 (2002).
  PubMed Google Scholar
• Annacker, O. et al. CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166, 3008–3018 (2001).
  CAS PubMed Google Scholar
• Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911–920 (2002).
  PubMed Google Scholar
• Hall, B. M., Jelbart, M. E., Gurley, K. E. & Dorsch, S. E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J. Exp. Med. 162, 1683–1694 (1985). This study provides the first evidence that transplantation tolerance can be transferred to naive recipients by CD4+CD25+ T cells.
  CAS PubMed Google Scholar
• Hall, B. M., Pearce, N. W., Gurley, K. E. & Dorsch, S. E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J. Exp. Med. 171, 141–157 (1990).
  CAS PubMed Google Scholar
• Cobbold, S. P., Qin, S., Leong, L. Y., Martin, G. & Waldmann, H. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol. Rev. 129, 165–201 (1992).
  CAS PubMed Google Scholar
• Bushell, A., Morris, P. J. & Wood, K. J. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T-cell regulation during the induction phase of the response. Eur. J. Immunol. 25, 2643–2649 (1995).
  CAS PubMed Google Scholar
• Onodera, K. et al. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J. Immunol. 157, 1944–1950 (1996).
  CAS PubMed Google Scholar
• Waldmann, H. & Cobbold, S. Regulating the immune response to transplants: a role for CD4+ regulatory cells? Immunity 14, 399–406 (2001).
  CAS PubMed Google Scholar
• Graca, L., Cobbold, S. P. & Waldmann, H. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195, 1641–1646 (2002).
  CAS PubMed PubMed Central Google Scholar
• Qin, S. et al. 'Infectious' transplantation tolerance. Science 259, 974–977 (1993). The first demonstration of infectious tolerance in a transplantation model.
  CAS PubMed Google Scholar
• Modigliani, Y. et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol. 26, 1807–1815 (1996).
  CAS PubMed Google Scholar
• Boitard, C., Yasunami, R., Dardenne, M. & Bach, J. F. T-cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169, 1669–1680 (1989). The first demonstration that CD4+ T cells can prevent the onset of a spontaneous autoimmune disease, namely insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.
  CAS PubMed Google Scholar
• Herbelin, A., Gombert, J. M., Lepault, F., Bach, J. F. & Chatenoud, L. Mature mainstream TCRαβ+CD4+ thymocytes expressing L-selectin mediate 'active tolerance' in the nonobese diabetic mouse. J. Immunol. 161, 2620–2628 (1998).
  CAS PubMed Google Scholar
• Lepault, F. & Gagnerault, M. C. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164, 240–247 (2000).
  CAS PubMed Google Scholar
• Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
  CAS PubMed Google Scholar
• Lando, Z., Teitelbaum, D. & Arnon, R. Effect of cyclophosphamide on suppressor-cell activity in mice unresponsive to EAE. J. Immunol. 123, 2156–2160 (1979).
  CAS PubMed Google Scholar
• Killen, J. A. & Swanborg, R. H. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells. J. Neuroimmunol. 3, 159–166 (1982).
  CAS PubMed Google Scholar
• Swierkosz, J. E. & Swanborg, R. H. Suppressor-cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol. 115, 631–633 (1975).
  CAS PubMed Google Scholar
• Yasunami, R. & Bach, J. F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481–484 (1988).
  CAS PubMed Google Scholar
• Sempe, P., Richard, M. F., Bach, J. F. & Boitard, C. Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse. Diabetologia 37, 337–343 (1994).
  CAS PubMed Google Scholar
• Billingham, R. E., Brent, L. & Medawar, P. B. Actively acquired tolerance to foreign cells. Nature 172, 603–606 (1953).
  CAS PubMed Google Scholar
• Miller, A., Lider, O. & Weiner, H. L. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174, 791–798 (1991). This study shows that tolerance induced by oral administration of myelin basic protein extends to other myelin antigens, providing the first demonstration of bystander suppression.
  CAS PubMed Google Scholar
• Weiner, H. L. et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12, 809–837 (1994).
  CAS PubMed Google Scholar
• Al-Sabbagh, A., Miller, A., Santos, L. M. & Weiner, H. L. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24, 2104–2109 (1994).
  CAS PubMed Google Scholar
• Davies, J. D., Leong, L. Y., Mellor, A., Cobbold, S. P. & Waldmann, H. T-cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156, 3602–3607 (1996).
  CAS PubMed Google Scholar
• Donckier, V. et al. Critical role of interleukin-4 in the induction of neonatal transplantation tolerance. Transplantation 59, 1571–1576 (1995).
  CAS PubMed Google Scholar
• Larsen, C. P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434–438 (1996).
  CAS PubMed Google Scholar
• Kirk, A. D. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 686–693 (1999).
  CAS PubMed Google Scholar
• Askenase, P. W., Hayden, B. J. & Gershon, R. K. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J. Exp. Med. 141, 697–702 (1975).
  CAS PubMed Google Scholar
• Seydel, K. et al. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model. Diabetes 40, 1430–1434 (1991).
  CAS PubMed Google Scholar
• Harrison, L. C., Dempsey-Collier, M., Kramer, D. R. & Takahashi, K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184, 2167–2174 (1996).
  CAS PubMed PubMed Central Google Scholar
• Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. & Enk, A. H. Induction of interleukin-10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213–1222 (2000).
  CAS PubMed PubMed Central Google Scholar
• Prudhomme, G. J. & Piccirillo, C. A. The inhibitory effects of transforming growth factor-β1 (TGF-β1) in autoimmune diseases. J. Autoimmun. 14, 23–42 (2000).
  CAS Google Scholar
• Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683–765 (2001).
  CAS PubMed Google Scholar
• Rapoport, M. J. et al. Interleukin-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178, 87–99 (1993).
  CAS PubMed Google Scholar
• Yamamoto, A. M. et al. The activity of immunoregulatory T cells mediating active tolerance is potentiated in non-obese diabetic mice by an IL-4-based retroviral gene therapy. J. Immunol. 166, 4973–4980 (2001).
  CAS PubMed Google Scholar
• Inobe, J. I., Chen, Y. & Weiner, H. L. In vivo administration of IL-4 induces TGF-β-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 778, 390–392 (1996).
  CAS PubMed Google Scholar
• Horsfall, A. C. et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J. Immunol. 159, 5687–5696 (1997).
  CAS PubMed Google Scholar
• Huang, T. J., MacAry, P. A., Wilke, T., Kemeny, D. M. & Chung, K. F. Inhibitory effects of endogenous and exogenous interferon-γ on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats. Immunology 98, 280–288 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bettelli, E. et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299–3306 (1998).
  CAS PubMed Google Scholar
• Bach, J. F. & Chatenoud, L. Tolerance to islet autoantigens and type I diabetes. Annu. Rev. Immunol. 19, 131–161 (2001).
  CAS PubMed Google Scholar
• Brocke, S. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343–346 (1996).
  CAS PubMed Google Scholar
• Young, D. A. et al. IL-4, IL-10, IL-13 and TGF-β from an altered peptide ligand-specific TH2-cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 164, 3563–3572 (2000).
  CAS PubMed Google Scholar
• Tisch, R., Wang, B. & Serreze, D. V. Induction of glutamic acid decarboxylase-65-specific TH2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163, 1178–1187 (1999).
  CAS PubMed Google Scholar
• Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. & Weiner, H. L. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237–1240 (1994).
  CAS PubMed Google Scholar
• Powrie, F., Carlino, J., Leach, M. W., Mauze, S. & Coffman, R. L. A critical role for transforming growth factor-β but not interleukin-4 in the suppression of T helper type 1-mediated colitis by CD45RBlowCD4+ T cells. J. Exp. Med. 183, 2669–2674 (1996).
  CAS PubMed Google Scholar
• Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995–1004 (1999).
  CAS PubMed PubMed Central Google Scholar
• Phillips, J. M., Parish, N. M., Drage, M. & Cooke, A. Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J. Immunol. 167, 6087–6091 (2001).
  CAS PubMed Google Scholar
• Seddon, B. & Mason, D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor-β and interleukin-4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+CD45RC− cells and CD4+CD8− thymocytes. J. Exp. Med. 189, 279–288 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bridoux, F. et al. Transforming growth factor-β (TGF-β)-dependent inhibition of T helper cell 2 (TH2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T-cell lines. J. Exp. Med. 185, 1769–1775 (1997).
  CAS PubMed PubMed Central Google Scholar
• Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. & Weiner, H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor-β after antigen-specific triggering. Proc. Natl Acad. Sci. USA 89, 421–425 (1992).
  CAS PubMed PubMed Central Google Scholar
• Josien, R. et al. A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102, 1920–1926 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kingsley, C. I., Karim, M., Bushell, A. R. & Wood, K. J. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080–1086 (2002).
  CAS PubMed Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969–1980 (1998).
  CAS PubMed Google Scholar
• Stephens, L. A. & Mason, D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25− subpopulations. J. Immunol. 165, 3105–3110 (2000).
  CAS PubMed Google Scholar
• Seddon, B., Saoudi, A., Nicholson, M. & Mason, D. CD4+CD8− thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur. J. Immunol. 26, 2702–2708 (1996).
  CAS PubMed Google Scholar
• Nakamura, K., Kitani, A. & Strober, W. Cell-contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell-surface-bound transforming growth factor-β. J. Exp. Med. 194, 629–644 (2001).
  CAS PubMed PubMed Central Google Scholar
• Piccirillo, C. A. et al. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor-β1 production and responsiveness. J. Exp. Med. 196, 237–246 (2002).
  CAS PubMed PubMed Central Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000).
  CAS PubMed PubMed Central Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
  CAS PubMed PubMed Central Google Scholar
• McHugh, R. S. et al. CD4+CD25+ immunoregulatory T cells: gene-expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311–323 (2002).
  CAS PubMed Google Scholar
• Zelenika, D. et al. Regulatory T cells overexpress a subset of TH2 gene transcripts. J. Immunol. 168, 1069–1079 (2002).
  CAS PubMed Google Scholar
• Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135–142 (2002).
  CAS Google Scholar
• Innes, J. B., Kuntz, M. M., Kim, Y. T. & Weksler, M. E. Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A. J. Clin. Invest. 64, 1608–1613 (1979).
  CAS PubMed PubMed Central Google Scholar
• Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin-2 production. J. Exp. Med. 188, 287–296 (1998).
  CAS PubMed PubMed Central Google Scholar
• Shevach, E. M. CD4+CD25+ suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389–400 (2002).
  CAS Google Scholar
• Apostolou, I., Sarukhan, A., Klein, L. & Von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol. 3, 756–763 (2002).
  CAS Google Scholar
• Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997). This paper shows that antigen-specific IL-10-dependent T R 1 cells grown in vitro can suppress colitis in vivo.
  CAS PubMed Google Scholar
• Taguchi, O. & Nishizuka, Y. Autoimmune oophoritis in thymectomized mice: T-cell requirement in adoptive cell transfer. Clin. Exp. Immunol. 42, 324–331 (1980).
  CAS PubMed PubMed Central Google Scholar
• Taguchi, O. & Nishizuka, Y. Experimental autoimmune orchitis after neonatal thymectomy in the mouse. Clin. Exp. Immunol. 46, 425–434 (1981).
  CAS PubMed PubMed Central Google Scholar
• McCullagh, P. The significance of immune suppression in normal self tolerance. Immunol. Rev. 149, 127–153 (1996).
  CAS PubMed Google Scholar
• Seddon, B. & Mason, D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189, 877–882 (1999).
  CAS PubMed PubMed Central Google Scholar
• Hara, M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789–3796 (2001).
  CAS PubMed Google Scholar
• Graca, L. et al. Both CD4+CD25+ and CD4+CD25− regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168, 5558–5565 (2002).
  CAS PubMed Google Scholar
• Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2R α-chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371–378 (1998).
  CAS PubMed Google Scholar
• Jordan, M. S. et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301–306 (2001).
  CAS Google Scholar
• Bensinger, S. J., Bandeira, A., Jordan, M. S., Caton, A. J. & Laufer, T. M. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells. J. Exp. Med. 194, 427–438 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357 (1986).
  CAS PubMed Google Scholar
• Bacchetta, R. et al. High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells. J. Exp. Med. 179, 493–502 (1994).
  CAS PubMed Google Scholar
• Gombert, J. M. et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989–2998 (1996).
  CAS PubMed Google Scholar
• Yoshimoto, T., Bendelac, A., Hu-Li, J. & Paul, W. E. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin-4. Proc. Natl Acad. Sci. USA 92, 11931–11934 (1995).
  CAS PubMed PubMed Central Google Scholar
• Wang, B., Geng, Y. B. & Wang, C. R. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320 (2001).
  PubMed PubMed Central Google Scholar
• Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14–Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839 (1998).
  CAS PubMed PubMed Central Google Scholar
• Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nature Med. 7, 1057–1062 (2001).
  CAS PubMed Google Scholar
• Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052–1056 (2001).
  CAS PubMed Google Scholar
• Lan, F. et al. Predominance of NK1.1+TCRαβ+ or DX5+TCRαβ+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: 'natural suppressor' cells. J. Immunol. 167, 2087–2096 (2001).
  CAS PubMed Google Scholar
• Peng, S. L. & Craft, J. T cells in murine lupus: propagation and regulation of disease. Mol. Biol. Rep. 23, 247–251 (1996).
  CAS PubMed Google Scholar
• Girardi, M. et al. Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195, 855–867 (2002).
  CAS PubMed PubMed Central Google Scholar
• Koh, D. R. et al. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8−/− mice. Science 256, 1210–1213 (1992).
  CAS PubMed Google Scholar
• Kumar, V. et al. Recombinant T-cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159, 5150–5156 (1997).
  CAS PubMed Google Scholar